News & Insights

Emergent Bioservices News, Insights & Events

Stay informed with news, insightful thought leadership, featured articles and engaging content from Emergent Bioservices and check out what events we’ll be attending throughout the year.

12.11.2021

Ondemand Webinar: HIGH-SPEED MANUFACTURING FOR YOUR VIRAL VACCINE OR THERAPEUTIC

Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...

11.19.2021

Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...

09.14.2021

Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B

Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies,...

08.30.2021

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...

08.19.2021

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...

07.23.2021

Arrival of the Groninger INTEGRA

With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...